心脏 - 移植中不断变化的指示和管理模式
Frederick M Lang1, Veli K Topkara2
1Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Current opinion in nephrology and hypertension
|November 5, 2024
概括
双心移植 (HKT) 为患有发达心脏和功能衰竭的患者提供了一个至关重要的策略. 新的器官共享联合网络 (UNOS) 政策标准化了指示,改善了同时心脏移植 (SHKT) 和心脏移植后移植 (KAHT) 的结果.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 移植医学 移植医学
背景情况:
- 双心移植 (HKT) 治疗终期心力衰竭与同时出现功能障碍.
- 越来越多的使用需要正式的指示和结果分析.
研究的目的:
- 审查HKT适应症的演变情况.
- 分析同时进行心移植 (SHKT) 和心脏移植后移植 (KAHT) 的结果.
- 讨论移植前后的管理以及未来的研究方向.
主要方法:
- 追溯结果研究为联合器官共享网络 (UNOS) 的政策制定提供了信息.
- 对接受SHKT和KAHT的患者群体的分析.
- 审查新型管理策略和新兴技术.
主要成果:
- 同时心脏移植 (SHKT) 在严重功能障碍的精选患者中显示出优于单器官心脏移植 (HT) 的优势.
- 心脏移植后的脏移植 (KAHT) 对于患有功能恶化的HT接受者来说是一个至关重要的选择.
- 移植前设备试验和氨酸抑制剂节省疗法改善了结果.
结论:
- 最近的进展完善了双重HKT接收者的选择和管理.
- 新的UNOS政策为HKT提供了必要的标准化.
- 双HKT代表了复杂患者病例的显著治疗进步.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
391
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
391
Heart Failure Drugs: Diuretics
345
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
345


